Skip to main content
SpringerLink
Log in

Public Health Implications of Emerging Vaccine Technologies

  • Chapter
Vaccine Design

Part of the book series: Pharmaceutical Biotechnology ((PBIO,volume 6))

Abstract

This book provides insight into recent innovations or improved applications of existing technologies in the design of vaccines for the prevention of several specific diseases. It makes a broader contribution to the understanding of the vast array of technologies that support modern vaccinology. The objectives of this chapter are: (1) to provide an overview of how advances in vaccine-related technologies have fostered the development of vaccines with highly desirable characteristics for current and future public health vaccination programs; (2) to explore how the development and availability of such vaccines will shape public health concepts, policies, and practices; and (3) to explore how institutional and procedural changes may alter vaccine research and development, manufacture, and delivery to populations in need of immunization.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Aguado, M. T., 1993, Future approaches to vaccine development: Single-dose vaccines using controlledrelease delivery systems, Vaccine 10:596–597.

    Article  Google Scholar 

  • Aitkin, R. J., Paterson, M., and Koothan, P. T., 1993, Contraceptive vaccines, Br. Med. Bull. 49:88–99.

    Google Scholar 

  • Bancroft, W. H., and Lemon, S. M., 1984, Hepatitis A from the military perspective, in: Hepatitis A (R.J. Garety, ed.), Academic Press, New York, pp. 81–100.

    Google Scholar 

  • Black, S., and Shinefield, H., 1995, Comprehensive evaluation of vaccine safety: Assessment of local and systemic side effects as well as emergency and hospitalization utilization. Proceedings of the combined vaccines and simultaneous administration: Current issues and perspectives workshop, Ann. N. Y. Acad. Sci. (in press).

    Google Scholar 

  • Brown, K. R., and Douglas, R. G., Jr., 1994, New challenges in quality control and licensure: Regulation, Int. J. Tech. Assess. Health Care 10:55–64.

    Article  CAS  Google Scholar 

  • Center for Biologics Evaluation and Research/FDA, 1995, Combined vaccines and simultaneous administration: Current issues and perspectives (Workshop sponsored by CBER/FDA, NVPO, NIAID/NIH, CDC, WHO, and held in Bethesda, MD, July 28–30,1993), Proceedings to be published in Ann. N. Y. Acad. Sci. Centers for Disease Control, 1982, Measles Surveillance Report No. 11, 1977–1981; Issued September, 1982.

    Google Scholar 

  • Centers for Disease Control, 1986, Hepatitis B associated with jet gun injection — California, Morbid. Mortal. Weekly Rep. 35:373–376.

    Google Scholar 

  • Centers for Disease Control and Prevention, 1993, Hantavirus infection — Southwestern United States: Interim recommendations for risk reduction, Morbid. Mortal. Weekly Rep. 42(Suppl. RR-11): 1–13.

    Google Scholar 

  • Centers for Disease Control and Prevention, 1994a, General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP), Morbid. Mortal. Weekly Rep. 43(Suppl. RR-1):1–38.

    Google Scholar 

  • Centers for Disease Control and Prevention, 1994b, Progress toward elimination of Haemophilus influenzae type b disease among infants and children — United States, 1987–1993, Morbid. Mortal. Weekly Rep. 43(No. 8): 144–148.

    Google Scholar 

  • Cheng, L., Ziegelhoffer, P. R., and Yang, N.-S., 1993, In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment, Proc. Natl. Acad. Sci. USA 90:4455–4459.

    Article  PubMed  CAS  Google Scholar 

  • Clemens, J., Brenner, R., and Rao, M., 1995, Interactions between PRP-T vaccine against Haemophilus influenzae type b and conventional infant vaccines: Lessons for further studies of simultaneous immunization and combined vaccines. Proceedings of the combined vaccines and simultaneous administration: Current issues and perspectives workshop, Ann. N.Y. Acad. Sci. (in press).

    Google Scholar 

  • Coates, J. B., Hoff, E. C., and Hoff, P. M., (eds.), 1963, Preventive Medicine in World War II. Vol. VI. Communicable Diseases: Malaria, Office of the Surgeon General, Department of the Army, Washington, DC.

    Google Scholar 

  • Cohen, S., Alonso, J. J., and Langer, R., 1994, Novel approaches to controlled-release antigen delivery, Int. J. Tech. Assess. Health Care 10:121–130.

    Article  CAS  Google Scholar 

  • de Quadros, C. A., Carrasco, P., and Olive, J.-M., 1994, The desired field-performance characteristics of new improved vaccines for the developing world, Int. J. Tech. Assess. Health Care 10:65–70.

    Article  Google Scholar 

  • Edelman, R., and Tacket, C. O., 1990, Adjuvants, Int. Rev. Immunol. 7:51–66.

    Article  PubMed  CAS  Google Scholar 

  • Ellis, R. W., and Douglas, R. G., Jr., 1994, New vaccine technologies, J. Am. Med. Assoc. 271:929–931.

    Article  CAS  Google Scholar 

  • Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes J. R., Santoro, J. C., and Robinson, H. L., 1993, DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations, Proc. Natl. Acad. Sci. USA. 90:11478–11482.

    Article  PubMed  CAS  Google Scholar 

  • Goldenthal, K. L., and McVittie, L. D., 1993, The clinical testing of preventive vaccines, in: Biologies Development: A Regulatory Overview (M. Mathieu, ed.), Parexel International Corp., Waltham, MA, pp. 119–130.

    Google Scholar 

  • Goldenthal, K. L., Cavagnaro, J. A., Alving, C. R., and Vogel, F. R., 1993, Safety evaluation of vaccine adjuvants: National cooperative vaccine development meeting working group, AIDS Res. Hum. Retroviruses 9:S47–S51.

    Google Scholar 

  • Henderson, D.A., and Fenner, F., 1994, Smallpox and vaccinia, in: Vaccines, 2nd ed. (S.A. Plotkin and E.A. Mortimer, Jr., eds.), Saunders, Philadelphia, pp. 13–40.

    Google Scholar 

  • Hoke, C. H., Jr., Binn, L. N., Egan, J. E., DeFraites, R. F., MacArthy, P. O., Innis, B. L., Eckels, K. H., Dubois, D., D’Hondt, E., Sjogren, M. H., Rice, R., Sadoff, J. C., and Bancroft, W. H., 1992, Hepatitis A in the US Army: Epidemiology and vaccine development, Vaccine 10(Suppl. 1):S75–S79.

    Article  PubMed  Google Scholar 

  • Homma, A., and Knouss, R. F., 1994, The transfer of vaccine technology to developing countries. The Latin American experience, Int. J. Tech. Assess. Health Care 10:47–54.

    Article  CAS  Google Scholar 

  • Hopkins, D. R., 1983, Princes and Peasants: Smallpox in History, University of Chicago Press, Chicago.

    Google Scholar 

  • The International Bank for Reconstruction and Development/World Bank, 1993, World Development Report 1993. Investing in Health, Oxford University Press, London.

    Google Scholar 

  • Johansson, B. E., Grajower, B., and Kilbourne, E. D., 1993, Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice, Vaccine 11:1037–1039.

    Article  PubMed  CAS  Google Scholar 

  • Jones, W. R., Bradley, J., Judd, S. J., Denholm, E. H., Ing, R. M. Y., Mueller, U. W., Powell, J., Griffin, P. D., and Stevens, V. C., 1988, Phase 1 clinical trial of a World Health Organization birth control vaccine, Lancet 1:1295–1298.

    Article  PubMed  CAS  Google Scholar 

  • La Montagne, J. R., and Rabinovich, N. R., 1994, The promise of new technologies, Int. J. Tech. Assess. Health Care 10:7–13.

    Article  Google Scholar 

  • Lemon, S. M., and Milstien, J. B., 1994, The thermostability of vaccines: Technologies for improving the thermostability of the oral poliovirus vaccine, Int. J. Tech. Assess. Health Care 10:177–184.

    Article  CAS  Google Scholar 

  • Martinez-Palomo, A. M., Lopez-Cervantes, M., and Freeman, P., 1994, The role of vaccine research and development in the scientific development of middle-income countries, Int. J. Tech. Assess. Health Care 10:30–38.

    Article  CAS  Google Scholar 

  • Melnick, J. L., 1994, Live attenuated poliovirus vaccines, in: Vaccines, 2nd ed. (S A. Plotkin and E. A. Mortimer, Jr., eds.), Saunders, Philadelphia, pp. 155–204.

    Google Scholar 

  • Mestecky, J., Kutteh, W. H., and Jackson, S., 1994, Mucosal immunity in the female genital tract: Relevance to vaccinations efforts against the human immunodeficiency virus, AIDS Res. Hum. Retroviruses 10(Suppl. 1) (in press).

    Google Scholar 

  • Miller, C. J., Alexander, N. J., and McChesney, M. B., 1994, Vaccines to prevent sexually transmitted diseases: The challenge of generating protective immunity at genital mucosal surfaces, in: Strategies in Vaccine Design (G.L. Ada, ed.), R.G. Landes Company, Austin, TX, pp. 193–212.

    Google Scholar 

  • Mitchell, M. S., Harel, W., Kan-Mitchell, J., LeMay, L. G., Goedegebuure, P., Huang, X. Q., Hofman, F., and Groshen, S., 1993, Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action, Ann. N.Y. Acad. Sci. 690:153–166.

    Article  PubMed  CAS  Google Scholar 

  • Mitchell, V. S., Philipose, N. M., and Sanford, J. P., (eds.), 1993, The Children’s Vaccine Initiative. Achieving the Vision, Institute of Medicine, National Academy Press, Washington, DC.

    Google Scholar 

  • National Academy of Science, Institute of Medicine, 1986, New vaccine development: Establishing priorities. Diseases of importance in the developing countries, National Academy Press, Washington, DC.

    Google Scholar 

  • National Institute of Allergy and Infectious Diseases, 1993, The Jordan Report. Accelerated Development of Vaccines — 1993, Bethesda, MD.

    Google Scholar 

  • Oaks, S. C., Mitchell, V. S., Pearson, G. W., and Carpenter, C. C. J., (eds.), 1991, Malaria: Obstacles and Opportunities, National Academy Press, Washington, DC.

    Google Scholar 

  • Ognibene, A. J., and Barrett, O., Jr., (eds.), 1982, Internal Medicine in Vietnam. Vol. II. General Medicine and Infectious Diseases, Office of the Surgeon General and Center of Military History, United States Army, Washington, DC.

    Google Scholar 

  • Parker, D., and Hill, T., 1994, The contribution of immunization to economic development, Int. J. Tech. Assess. Health Care 10:21–29.

    Article  CAS  Google Scholar 

  • Parkman, P. D., and Hardegree, M. C., 1994, Regulation and testing of vaccines, in: Vaccines, 2nd ed. (S. A. Plotkin and E. A. Mortimer, Jr., eds.), Saunders, Philadelphia, pp. 889–901.

    Google Scholar 

  • Patriarca, P. A., Wright, P. F., and John, T. J., 1991, Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: A review, Rev. Infect. Dis. 13:926–939.

    Article  PubMed  CAS  Google Scholar 

  • Plotkin, S. L., and Plotkin, S. A., 1994, A short history of vaccination, in: Vaccines, 2nd ed. (S. A. Plotkin and E. A. Mortimer, Jr., eds.), Saunders, Philadelphia, pp. 1–11.

    Google Scholar 

  • Robbins, A., and Arita, I., 1994, The global capacity for manufacturing vaccines. Prospects for competition and collaboration among producers in the next decade, Int. J. Tech. Assess. Health Care 10:39–46.

    Article  CAS  Google Scholar 

  • Safranek, T. J., Lawrence, D. N., Kurland, L. T., Culver, D. H., Wiederholt, W. C., Hayner, N. S., Osterholm, M. T., O’Brien, P., Hughes, J. M, and the Expert Neurology Group, 1991, Reassessment of the association between Guillain-Barre syndrome and receipt of swine influenza vaccine in 1976–1977: Results of a two-state study, Am. J. Epidemiol. 133:940–951.

    PubMed  CAS  Google Scholar 

  • Smith, S. J., Lawrence, D. N., and Noble, G. R., 1984, An immune response profile model for immunogenicity quantitation, J. Theor. Biol. 110:1–10.

    Article  PubMed  CAS  Google Scholar 

  • Ward, J., Lieberman, J. M., and Cochi, S. L., 1994, Haemophilus influenzae vaccines in: Vaccines, 2nd ed. (S.A. Plotkin and E.A. Mortimer, Jr., eds.), Saunders, Philadelphia, pp. 337–386.

    Google Scholar 

  • Wassilak, S. G. F., Glasser, J. W., Chen, R. T., and Hadler, S. C., 1995, Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects, in: Proceedings of the workshop on combined vaccines and simultaneous administration: Current issues and perspectives, Ann. N.Y. Acad. Sci. (in press).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892, USA

    Dale N. Lawrence

  2. Division of Vaccines and Related Products Applications, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland, 20852, USA

    Karen L. Goldenthal & Donna K. F. Chandler

  3. Walter Reed Army Institute of Research, Washington, D.C., 20307, USA

    John W. Boslego

  4. Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892, USA

    John R. La Montagne

Authors
  1. Dale N. Lawrence
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen L. Goldenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John W. Boslego
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Donna K. F. Chandler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John R. La Montagne
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Genentech, Inc., South San Francisco, California, USA

    Michael F. Powell

  2. Vaxcel, Inc., Norcross, Georgia, USA

    Mark J. Newman

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lawrence, D.N., Goldenthal, K.L., Boslego, J.W., Chandler, D.K.F., La Montagne, J.R. (1995). Public Health Implications of Emerging Vaccine Technologies. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1823-5_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5737-7

  • Online ISBN: 978-1-4615-1823-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation